Citations

Clear

4 citation(s) found for "Kelleher, Thomas".

Frailty and postoperative outcomes following craniopharyngioma resection: a multicenter Registry for Adenomas of the Pituitary and Related Disorders analysis
Chen, Anthony Yulin, Feng, Rui, Collopy, Calen, Rennert, Robert C., Couldwell, William T., Kshettry, Varun R., Gardner, Paul, Silverstein, Julie M., Kim, Albert H., Barkhoudarian, Garni, Kelly, Daniel, Pacione, Donato , Suryadevara, Carter M. , Kim, Won, Bergsneider, Marvin, Zada, Gabriel, Wu, Kyle C., Prevedello, Daniel M., BENJAMIN, CAROLINA, Catalino, Michael P., Mamelak, Adam, Cheok, Stephanie K., Zwagerman, Nathan T., Gompel, Jamie J. Van, Fernandez-Miranda, Juan C., Yuen, Kevin C. J., Little, Andrew S., Karsy, Michael, Evans, James J., Karsy, Michael , Barkhoudarian, Garni , Palit, Sandhya R. , Karsy, Michael , Kelleher, Sean T., Rennert, Robert C , Couldwell, William T. , Kshettry, Varun R. , Silverstein, Julie , Kim, Albert H , Kelly, Daniel, Bergsneider, Marvin , Chicoine, Michael , Zada, Gabriel , Prevedello, Daniel M. , Catalino, Michael Paul, Mamelak, Adam N. , Cheok, Stephanie , Zwagerman, Nathan T. , Gompel, Jamie J. Van , Fernandez‐Miranda, Juan C. , Yuen, Kevin C.J. , Little, Andrew S. , Evans, James J.

Mayo Clinic

Neurosurgical Focus | May 27, 2026 | Volume: 60 | Issue: 6 | Pages: E7

10.3171/2026.2.focus251160 | PMID 42224740 Get It

OBJECTIVE Frailty is a known predictor of adverse outcomes in pituitary surgery, yet its impact regarding craniopharyngioma remains unclear. The authors assessed preoperative frailty, measured by the 11-factor modified frailty index (mFI-11), and its association with perioperative morbidity among adult patients undergoing craniopharyngioma surgery. METHODS Using the Registry for Adenomas of the Pituitary and Related Disorders (RAPID) database, the authors performed a retrospective cohort study of the records of patients ≥ 18 years of age who underwent craniopharyngioma surgery between June 2007 and November 2024. Patients were stratified into the following categories according to their numeric mFI-11 score: fit (scores 0 and 1), managing well (scores 2 and 3), and mildly frail (scores 4–6). Primary outcomes included hospital length of stay (LOS) and discharge disposition. Secondary outcomes included 90-day readmission, surgical outcomes, and complications. Multivariable analyses were performed to identify independent predictors of hospital LOS and non-home discharge, adjusting for age, surgeon experience, American Society of Anesthesiologists class, complications, and surgical approach. RESULTS Among 278 patients (221 fit, 43 managing well, 14 mildly frail), higher-frailty patients were older (mean age 47.8 ± 16.1 years in fit vs 60.1 ± 12.5 years in managing well vs 67.6 ± 8 years in mildly frail, p < 0.001) and more likely to present urgently (24.2% vs 36.4% vs 78.6%, p = 0.001). Gross-total resection was achieved less frequently in frail patients (44.8% vs 24.3% vs 23.1%, p = 0.030). Overall complication rates were similar; however, increasing frailty was associated with higher rates of postoperative mortality (0% vs 2.8% [1/36] vs 7.7% [1/13], p = 0.018), pneumonia (0.5% [1/195] vs 2.8% [1/36] vs 15.4% [2/13], p = 0.006), and reintubation (2.6% [5/195] vs 2.8% [1/36] vs 30.8% [4/13], p = 0.002). Higher frailty was associated with a stepwise rise in median [IQR] LOS (5 [3–8] days vs 7 [4–12] days vs 13 [6.5–21.8] days, p < 0.001) and remained an independent predictor of extended LOS on multivariable analysis (β = 1.729 per point, p = 0.006). Rates of non-home discharge showed a similar pattern (9.2% vs 30.0% vs 64.3%, p < 0.001), with frailty independently predicting non-home discharge (OR 2.352, 95% CI 1.527–3.822). Unplanned 90-day readmission rates were significantly higher in the mildly frail cohorts (22.5% vs 45.7% vs 53.8%, p = 0.002). CONCLUSIONS The mFI-11 scores independently predicted perioperative morbidity following craniopharyngioma resection. Incorporating frailty screening into preoperative screening may improve risk stratification, family and patient counseling, and discharge planning.
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease
Hill, David , Schwarz, Adam J. , Isaac, Maria , Pani, Luca , Vamvakas, Spiros, Hemmings, Robert , Carrillo, María C. , Yu, Peng , Sun, Jia , Boccardi, Marina , Brewer, James B., Brumfield, Martha A., Cantillon, Marc, Cole, Patricia E., Fox, Nick C. , Frisoni, Giovanni B. , Kelleher, Thomas, Luo, Feng , Novak, Gerald , Maguire, Paul, Meibach, Richard C., Patterson, Patricia, Bain, Lisa J. , Raunig, David , Soares, Holly , Suhy, Joyce, Wang, Huanli , Wolz, Robin, Stephenson, Diane , Boccardi, Marina , Frisoni, Giovanni B. , Beckett, Laurel , Jack, Clifford R. , Maguire, Paul, Sampaio, Cristina , Fox, Nick C

Mayo Clinic

Alzheimer's & Dementia | June 28, 2014 | Volume: 10 | Issue: 4 | Pages: 421

10.1016/j.jalz.2013.07.003 | PMID 24985687 Get It

AbstractBackgroundRegulatory qualification of a biomarker for a defined context of use provides scientifically robust assurances to sponsors and regulators that accelerate appropriate adoption of biomarkers into drug development.MethodsThe Coalition Against Major Diseases submitted a dossier to the Scientific Advice Working Party of the European Medicines Agency requesting a qualification opinion on the use of hippocampal volume as a biomarker for enriching clinical trials in subjects with mild cognitive impairment, incorporating a scientific rationale, a literature review and a de novo analysis of Alzheimer's Disease Neuroimaging Initiative data.ResultsThe literature review and de novo analysis were consistent with the proposed context of use, and the Committee for Medicinal Products for Human Use released an opinion in November 2011.ConclusionsWe summarize the scientific rationale and the data that supported the first qualification of an imaging biomarker by the European Medicines Agency.
IC‐P‐041: Prediction of disease progression in mild cognitive impairment from vMRI and concordance with CSF biomarkers
Yu, Peng , Schwarz, Adam J. , Sun, Jia , Kelleher, Thomas, Wang, Huanli , Davidson, Chris, Frank, Denise, Cole, Patricia E., Hill, David , Beckett, Laurel , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2012.05.073 Get It

O2‐11‐01: Prediction of disease progression in mild cognitive impairment from vMRI and concordance with cerebrospinal fluid biomarkers
Yu, Peng , Schwarz, Adam J. , Sun, Jia , Kelleher, Thomas, Wang, Huanli , Davidson, Chris, Frank, Denise, Cole, Patricia E., Hill, David , Beckett, Laurel , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2012.05.684 Get It